November, 2025 The New Jersey Supreme Court has consolidated lawsuits alleging injuries from Ozempic and other GLP-1 medications into two separate multicounty litigations (MCLs) under Bergen County Superior Court Judge Gregg A
Based on the reluctance of major Part D plan sponsors to participate in the BALANCE Model in 2027 under the original specifications, it appears that sponsors had insufficient data to estimate their added costs associated with covering GLP-1s for obesity
Zietek, T., Rath, E., Haller, D., Daniel, H., & Mssig, K
Signup now Already a member
Provider Licensing Requirements Core Rule: Providers must be licensed in the state where the patient is located
Lets break it down by thyroid condition: Primary Hypothyroidism Usually safe